Nexalin Technology NXL
NASDAQ NXL
$0.33 +0.00 (+0.03%)
At close: Aug 20, 2026 · 12:43 PM UTC

Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026)

Nexalin Technology (NXL) posted quarterly Change in Acquisitions & Divestments of $5.6 million for Q1 2026, down 13.95% year-over-year from $6.5 million in Q1 2025, and down 41.03% quarter-over-quarter from $9.5 million in Q4 2025.

Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends

Nexalin Technology's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $5.6 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 13.95% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $39.8 million (up 18.91% YoY), while the FY2025 annual figure was $40.7 million, up 22.58% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $5.6 million, down from $9.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $13.5 million in Q3 2025, with the low at $2.9 million in Q2 2024.
  • The 4-year median for Change in Acquisitions & Divestments is $9.6 million (2023), against an average of $9.3 million.
  • The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments sank 69.29% in 2024, then soared 281.83% in 2025.
  • Nexalin Technology's Change in Acquisitions & Divestments stood at $8.6 million in 2023, then rose by 26.36% to $10.9 million in 2024, then dropped by 12.85% to $9.5 million in 2025, then sank by 41.03% to $5.6 million in 2026.
  • Business Quant data shows NXL's Change in Acquisitions & Divestments at $5.6 million in Q1 2026, $9.5 million in Q4 2025, and $13.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 Nexalin Technology 6.98 Mn 5.97 Mn 8,897.00

Historic Data

Download Data
DateValue
Mar 31, 2026 5.59 Mn
Mar 31, 2026 5.59 Mn
Dec 31, 2025 9.48 Mn
Dec 31, 2025 9.48 Mn
Sep 30, 2025 13.55 Mn
Sep 30, 2025 13.55 Mn
Jun 30, 2025 11.21 Mn
Jun 30, 2025 11.21 Mn
Mar 31, 2025 6.50 Mn
Mar 31, 2025 6.50 Mn
Dec 31, 2024 10.88 Mn
Dec 31, 2024 10.88 Mn
Sep 30, 2024 13.18 Mn
Sep 30, 2024 13.18 Mn
Jun 30, 2024 2.93 Mn
Jun 30, 2024 2.93 Mn
Mar 31, 2024 6.24 Mn
Mar 31, 2024 6.24 Mn
Dec 31, 2023 8.61 Mn
Dec 31, 2023 8.61 Mn